Back
180 Life Sciences 10K Form
Sell
27
ATNF
180 Life Sciences
Last Price:
1.49
Seasonality Move:
-11.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-05 | 10Q | ATNF/180 Life Sciences Quarterly |
| 2020-11-24 | 10Q | ATNF/180 Life Sciences Quarterly |
| 2020-08-20 | 10Q | ATNF/180 Life Sciences Quarterly |
| 2020-05-22 | 10Q | ATNF/180 Life Sciences Quarterly |
| 2020-04-07 | 10K | ATNF/180 Life Sciences Annual |
| 2019-11-12 | 10Q | ATNF/180 Life Sciences Quarterly |
Receive ATNF News And Ratings
See the #1 stock for the next 7 days that we like better than ATNF
ATNF Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.03M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.12 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -41.78490 |
|---|---|
| Net Income (TTM): | $-16.24M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
180 Life Sciences Earnings Forecast
Key 180 Life Sciences Financial Ratios
- The Interest Expense is -0.22% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 3 years.
180 Life Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATNF |
| CUSIP: | 68236V |
| Website: | 180lifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATNF Technical Analysis vs Fundamental Analysis
Sell
27
180 Life Sciences (ATNF)
is a Sell
Is 180 Life Sciences a Buy or a Sell?
-
180 Life Sciences stock is rated a Sell
The current 180 Life Sciences [ATNF] share price is $1.50. The Score for ATNF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.